Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Grazia Refolo

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Frontiers in Oncology|April 25, 2022
Variations in Circulating Levels of Angiopoietin-2 Over Time Are Predictive of Ramucirumab-Paclitaxel Therapy Outcome in Advanced Gastric Cancer: Results of Prospective StudyRosalba D'Alessandro, Maria Grazia Refolo, Annalisa Schirizzi, et al.
Journal of Clinical Medicine|November 27, 2024
StepFit-18K: Improving Irritable Bowel Syndrome (IBS) Symptoms with a Simple, Structured Walking InterventionIsabella Franco, Antonella Bianco, Laura Prospero, et al.
Frontiers in Oncology|May 1, 2023
Corrigendum: Variations in circulating levels of angiopoietin-2 over time are predictive of ramucirumab-paclitaxel therapy outcome in advanced gastric cancer: results of prospective studyRosalba D'Alessandro, Maria Grazia Refolo, Annalisa Schirizzi, et al.
International Journal of Molecular Sciences|April 30, 2021
Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle InterventionsMaria Notarnicola, Alberto Ruben Osella, Maria Gabriella Caruso, et al.
Frontiers in Oncology|March 6, 2023
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell linesAnnalisa Schirizzi, Marialessandra Contino, Livianna Carrieri, et al.
Biomedicines|October 28, 2023
VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based TreatmentAnnalisa Schirizzi, Aram Arshadi, Doron Tolomeo, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Frontiers in Oncology|April 25, 2022
Variations in Circulating Levels of Angiopoietin-2 Over Time Are Predictive of Ramucirumab-Paclitaxel Therapy Outcome in Advanced Gastric Cancer: Results of Prospective StudyRosalba D'Alessandro, Maria Grazia Refolo, Annalisa Schirizzi, et al.
Journal of Clinical Medicine|November 27, 2024
StepFit-18K: Improving Irritable Bowel Syndrome (IBS) Symptoms with a Simple, Structured Walking InterventionIsabella Franco, Antonella Bianco, Laura Prospero, et al.
Frontiers in Oncology|May 1, 2023
Corrigendum: Variations in circulating levels of angiopoietin-2 over time are predictive of ramucirumab-paclitaxel therapy outcome in advanced gastric cancer: results of prospective studyRosalba D'Alessandro, Maria Grazia Refolo, Annalisa Schirizzi, et al.
International Journal of Molecular Sciences|April 30, 2021
Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle InterventionsMaria Notarnicola, Alberto Ruben Osella, Maria Gabriella Caruso, et al.
Frontiers in Oncology|March 6, 2023
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell linesAnnalisa Schirizzi, Marialessandra Contino, Livianna Carrieri, et al.
Biomedicines|October 28, 2023
VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based TreatmentAnnalisa Schirizzi, Aram Arshadi, Doron Tolomeo, et al.
Pageof 3